These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6453032)

  • 1. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin.
    Bonnevie-Nielsen V; Steffes MW; Lernmark A
    Diabetes; 1981 May; 30(5):424-9. PubMed ID: 6453032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia.
    Bonner-Weir S; Trent DF; Honey RN; Weir GC
    Diabetes; 1981 Jan; 30(1):64-9. PubMed ID: 6112177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diabetes on islet area and beta-cell function.
    Bonnevie-Nielsen V; Lernmark A
    Acta Biol Med Ger; 1981; 40(1):77-81. PubMed ID: 7020308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice.
    Karabatas LM; Pastorale C; de Bruno LF; Maschi F; Pivetta OH; Lombardo YB; Chemes H; Basabe JC
    Pancreas; 2005 May; 30(4):318-24. PubMed ID: 15841040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of (-)15-deoxyspergualin on pancreatic islet B-cell function in vitro and on the development of diabetes after multiple low dose streptozotocin administration.
    Strandell E; Andersson A; Groth CG; Sandler S
    Pharmacol Toxicol; 1989 Aug; 65(2):114-8. PubMed ID: 2530505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
    Sandler S; Swenne I
    Diabetes Res; 1985 Sep; 2(5):255-8. PubMed ID: 2933209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
    Zeng CJ; Zhang L; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age.
    Riley WJ; McConnell TJ; Maclaren NK; McLaughlin JV; Taylor G
    Diabetes; 1981 Sep; 30(9):718-23. PubMed ID: 6455320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.
    Rossini AA; Appel MC; Williams RM; Like AA
    Diabetes; 1977 Oct; 26(10):916-20. PubMed ID: 143386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability of pancreatic islets after administration of streptozotocin.
    Sandler S; Jansson L
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):359-67. PubMed ID: 2413613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of pancreatic islets to different alkylating agents decreases mitochondrial DNA content but only streptozotocin induces long-lasting functional impairment of B-cells.
    Eizirik DL; Sandler S; Ahnström G; Welsh M
    Biochem Pharmacol; 1991 Nov; 42(12):2275-82. PubMed ID: 1837218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemia.
    Chang TJ; Weaver JR; Bowman A; Leone K; Raab R; Vinik AI; Pittenger GL; Taylor-Fishwick DA
    Mol Cell Endocrinol; 2011 Mar; 335(2):104-9. PubMed ID: 21187123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure.
    Eizirik DL; Sandler S; Sener A; Malaisse WJ
    Endocrinology; 1988 Aug; 123(2):1001-7. PubMed ID: 2969323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes.
    Guz Y; Nasir I; Teitelman G
    Endocrinology; 2001 Nov; 142(11):4956-68. PubMed ID: 11606464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.
    Korsgren O; Jansson L; Sandler S; Andersson A
    J Clin Invest; 1990 Dec; 86(6):2161-8. PubMed ID: 2254465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.